32,041 Shares in CME Group Inc. $CME Purchased by Keystone Financial Planning Inc.

21 Mar 2026, 07:35 by Teresa Graham · The Cerbat Gem

Keystone Financial Planning Inc. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 32,041 shares of the financial services provider’s stock, valued at approximately $8,750,000. CME Group comprises approximately 2.5% of Keystone Financial Planning Inc.’s holdings, making the stock its 9th largest position.

Several other institutional investors have also added to or reduced their stakes in the company. MBM Wealth Consultants LLC raised its holdings in shares of CME Group by 2.7% during the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after acquiring an additional 37 shares in the last quarter. West Family Investments Inc. grew its holdings in shares of CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its holdings in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares in the last quarter. Atlatl Advisers LLC raised its stake in CME Group by 1.8% during the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares in the last quarter. Finally, 1248 Management LLC lifted its position in CME Group by 26.8% during the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME raised its quarterly dividend to $1.30 (annualized $5.20), a payout increase that supports yield-focused holders and signals confidence in cash generation. See company summary. MarketBeat: CME summary
Neutral Sentiment: Analyst actions are mixed — several firms have raised price targets and ratings (Jefferies, Weiss, Erste), while others remain cautious or underweight (JPMorgan, Goldman). The consensus view is close to a “Hold” with a median target near the current price, producing offsetting pressure on the stock. See analyst roundup. MarketBeat: analyst notes
Neutral Sentiment: Short-interest notices published this week show zero shares/days-to-cover, which appears to be a data error (NaN/inconsistent reporting) and should not be treated as a meaningful change in market sentiment. No reliable short-squeeze signal. (No credible link — data feed report)
Neutral Sentiment: Institutional ownership remains high and activity is mixed: large buy and sell moves by different funds have been reported in recent filings, so institutional flow is not clearly one-directional. MarketBeat: institutional activity
Negative Sentiment: Senior management insider selling: General Counsel Jonathan L. Marcus sold 3,291 shares (around $1.1M) on March 17, reducing his holding by ~31%. Multiple recent insider sales by executives have been highlighted by data aggregators, which can weigh on sentiment even if sales are routine or for diversification. InsiderTrades: Marcus sale

CME Group Trading Down 1.1%

Shares of CME opened at $307.32 on Friday. The company’s fifty day simple moving average is $300.08 and its 200-day simple moving average is $280.42. The company has a market cap of $110.82 billion, a P/E ratio of 27.54, a P/E/G ratio of 3.36 and a beta of 0.24. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $248.53 and a twelve month high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the previous year, the company earned $2.52 EPS. As a group, analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is presently 46.59%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group boosted their target price on shares of CME Group from $266.00 to $275.00 and gave the stock a “sell” rating in a report on Monday, March 16th. Raymond James Financial dropped their price target on CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. UBS Group reissued a “neutral” rating and set a $310.00 price objective on shares of CME Group in a research note on Friday, February 6th. Bank of America upped their price objective on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Finally, Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $304.06.

View Our Latest Research Report on CME

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the sale, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares of the company’s stock, valued at $7,647,194.10. This represents a 1.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 8,539 shares of company stock valued at $2,713,821. Company insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.